Vinod P. Shah, Ph.D., FAAPS – Founding President
Dr. Shah is a pharmaceutical consultant. He retired from the US FDA (Food and Drug Administration) after serving for 30 years. While at the FDA, he developed several Regulatory Guidances for the Pharmaceutical Industry in the area of biopharmaceutics, including a guidance on the dissolution of IR and ER products. He is the author/co-author of over 290 scientific papers and co-editor of three books. He is a recipient of the FDA Award of Merit, FIP Lifetime Achievement Award in Pharmaceutical Sciences and has an Honorary Doctorate from Semmelweis University (Budapest, Hungary).
Frank Minalga, CPA – Treasurer
Frank Minalga is the Chief Financial Officer of SOTAX Corporation in Westborough, MA. He is a licensed Certified Public Accountant with 21 years of experience in areas of taxation and financial reporting. After graduating from Rutgers University, Frank spent eight years in public accounting. His public accounting work included tax preparation and planning for high net worth individuals and companies as well as audited and reviewed financial statements. Frank played an integral part in SOTAX’s acquisitions and successful integrations of Zymark and Pharmatron.
Sanjaykumar Patel – Director
Sanjaykumar Patel is Assoc. Principal Scientist at Merck & Co., Inc. in Rahway, NJ. He has 18 years of experience in pharmaceuticals industry. His experience includes working on novel drug delivery formulations such as self-emulsifying drug delivery systems, amorphous solid dispersion, controlled release and gastro retentive, and parental formulation. His research interest is focused on developing predictive bio-relevant in-vitro methodologies to understand in-vivo performance of oral and parental formulations. He has co-authored several scientific papers. He is an active member of AAPS and a part of the IVRDT (In Vitro Release and Dissolution Testing) focus group steering committee. He is involved in cross-organization consortium, OrBiTo, in the area focusing on a development and improvement of in-vitro analytical tools.
Patrick Ballmer – Director
Patrick serves as Vice President and Deputy of the CEO of the Aesch, BL, Switzerland headquartered SOTAX Group. Raised in Switzerland and educated at ETH Zurich, he moved to Pennsylvania in 2005 and Massachusetts in 2009 to develop the presence of SOTAX in the United States. Today he oversees all activities of SOTAX in North- and South America, including Production, Product Development and Application Laboratories at SOTAX in Westborough, MA. An immigrant to the US himself, he particularly enjoyed working with and developing solutions for immigrant scientists from the Indian subcontinent and elsewhere through his tenure at SOTAX.
Jerome Morris – Director
Jerome Morris is the Sales Director at SOTAX located in Denver, CO supporting the USA Region. He received a BS in Chemistry from Benedictine College and a MS in Chemistry from University of Denver. Before joining SOTAX, he had many years of experience within the pharmaceutical sector, notably Pharmacia & Upjohn, Atrix Laboratories/QLT Inc and most recent as an AR&D Sr. Scientist of dissolution technology at Novartis in Broomfield, Colorado. This position included working closely with the formulation group to develop dissolution methods for QC release, establishing IVIVC’s and performing bioequivalence tests. During his dissolution research, he evaluated topical semi-solid products, microspheres, implants and solid oral formulations that were immediate release, delayed release, modified release and extended release in design.